Location of Repository

In vitro activities of the biguanide PS-15 and its metabolite, WR99210, against cycloguanil-resistant Plasmodium falciparum isolates from Thailand

By MD Edstein, S Bahr, B Kotecka, GD Shanks and KH Rieckmann

Abstract

The in vitro activities of the new biguanide PS-15 and its putative active metabolite, WR99210, were determined against seven different isolates or clones of Plasmodium falciparum. The mean 50% inhibitory concentrations of PS-15 and WR99210 were 1,015 and 0.06 ng/ml, respectively. WR99210 was up to 363 times more potent than cycloguanil, the active metabolite of proguanil, against cycloguanil-resistant parasites. The pronounced activity of WR99210 against multidrug-resistant P. falciparum indicates that further studies are required to determine the value of the prodrug, PS-15, as an antimalarial agent

Topics: Antimalarial, Invitro
Publisher: AMER SOC MICROBIOLOGY
Year: 1997
OAI identifier: oai:espace.library.uq.edu.au:UQ:329275

Suggested articles

Preview


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.